1 Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes The American Journal of Cardiology, April 4, 2014
2 Favourable 5-year postdischarge survival of comatose patients resuscitated from out-of-hospital cardiac arrest, managed with immediate coronary angiogram on admission European Heart Journal: Acute Cardiovascular Care, February 27, 2014
3 Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non–ST-segment–elevation acute coronary syndromes or stable ischemic heart disease Circulation: Cardiovascular Interventions, June 20, 2014
4 B-type natriuretic peptide and risk of acute kidney injury in patients hospitalized with acute coronary syndromes Critical Care Medicine, February 19, 2014
5 Impact of continuous deterioration of kidney function 6 to 8 months after percutaneous coronary intervention for acute coronary syndrome The American Journal of Cardiology, May 6, 2014
Question: True or false: In patients with STEMI, an investigational trial of IV glucose-insulin-potassium treatment significantly reduced the risk of composites cardiac arrest and/or mortality with and without HF hospitalization within 1 year.
Question: A 54-year-old patient with history of ACS six months ago presents to your office for follow-up and notes generalized aches and pains along with depression. He has no prior history of depression. Based on recent data, at the time of his ACS what could have predicted his current depressive symptoms?
2015 © M3 USA. ALL Rights Reserved.